Investment in the sector must be selective. Grifols, Rovi and Faes will be the favorites in Spain. In Europe and the US, Sanofi, Roche, Pfizer and J&J are attractive.
The pharmaceutical sector has gone into the background in the year after the pandemic began, but it has rises this year and opportunities beyond Covid-19, just one after that Pfizer publish the high efficiency rates of its
To continue reading become Premium
Try it for € 1 the first month
and enjoy unlimited access to all Expansión web content
–
Already Premium? Beautify
–
–
– .
Related posts:
The President's Health Adviser reveals the causes of the increase in Corona deaths
"Seat Ibiza overturns on Flers bypass in Orne, driver taken to hospital"
"Reach for the ruler": a simple test that will show if you have osteochondrosis
Parents in Indonesia often say it arbitrarily, in fact these 7 sentences are precisely what the litt...
